Tigecycline

This page contains recent news articles, when available, and an overview of Tigecycline but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Margulis: Peer Review Or "Cycle Of Submission"?  -  ‎Jan 4, 2010‎
One of them, "Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic Tigecycline", the authors say involves an ... Scoop.co.nz

Unimark Remedies to push formulations biz in India  -  ‎Jan 1, 2010‎
It also markets a unique product Divercil (Tigecycline) for treating life-threatening infections. Zen is also planning to increase the number of medical ... Business Standard

Court Report  -  ‎Dec 20, 2009‎
...to manufacture a generic version of Wyeth's Tygacil® (tigecycline injectible, used for the treatment of complicated skin and skin structure infections, ... Patent Docs (blog)

�?�리�?�지�?성장용정 5mg 급여 �?�정  -  ‎Dec 22, 2009‎
...�?한 Tigecycline주사제(품명:타�?�가실주)�?� 급여기준�?� 변경�?�다. �?염전문가 �?문 하�? 기존 모든 항�?제�? 내성�?� 보�?�는 그람�?�성균 �?염�? 투여한 경우 약값 전액 ... 메디파나뉴스

타�?�가실주, 항�?제 내성�? 본�?�부담 급여  -  ‎Dec 30, 2009‎
...개정 고시를 보면 Tigecycline주사제�?� '타�?�가실주'는 허가사항�?� 초과해 �?염전문가�?� �?문 하�? 기존 모든 항�?제�? 내성�?� 보�?�는 그람 �?�성균 �?염�? 투여한 경우 ... 데일리팜

FDA Approves Superbug Antibiotic, Tygacil (tigecycline)  -  Jun 17, 2005
The US FDA has approved Tygacil™ (tigecycline), a novel IV antibiotic with a broad spectrum of antimicrobial activity, including activity against the ... Medical News Today - Medical News Today (press release)

Tigecycline (Tygacil): the first in the glycylcycline class of...  -  Apr 1, 2006
Tigecycline is the first drug in the glycylcycline class of antibiotics. Although it is structurally related to minocycline, alterations to the molecule ... Free with registration - Baylor University Medical Center... - AccessMyLibrary.com

Tigecycline: a novel glycylcycline antibiotic.(Focus on ...)  -  Aug 1, 2005
Highly resistant strains of both gram-positive and gram-negative bacteria are becoming commonplace in both the inpatient and outpatient setting. ... Free with registration - Formulary - AccessMyLibrary.com

Tigecycline for serious infections.(Safety and Efficacy Issues)  -  Sep 22, 2006
Australia -- Tigecycline (Tygacil[R]) vials containing 50 mg lyophilised powder for reconstitution have been approved for complicated skin and soft tissue ... Free with registration - WHO Drug Information - AccessMyLibrary.com

Efficacy of Tigecycline Compared to Levofloxacin for Treating …  -  Apr 5, 2007
By Chris Berrie. MUNICH, GERMANY -- April 5, 2007 -- The first-in-class glycylcycline agent, tigecycline, appears safe and shows a clinical cure rate that ... DG News

Tigecycline Associated with Cure Rates Similar to Levofloxacin in …  -  Oct 4, 2006
By Paula Moyer. SAN FRANCISCO, CA -- October 4, 2006 -- Patients are hospitalized with community-acquired pneumonia have a cure rate of 89.7% when they are ... DG News

Tigecycline promising for complicated infections: first antibiotic in...  -  Jan 15, 2005
WASHINGTON -- Tigecycline, a novel broad-spectrum antibiotic, appears effective in treating a variety of serious infections, including those caused by ... Free with registration - Family Practice News - AccessMyLibrary.com

Tigecycline tested as CAP therapy.(Infectious Diseases)  -  Dec 1, 2006
SAN FRANCISCO -- Tigecycline appeared to be comparable in efficacy and tolerability to levofloxacin in treating community-acquired pneumonia in two phase ... Free with registration - Internal Medicine News - AccessMyLibrary.com

Tigecycline matches levofloxacin vs. pneumonia.(Infectious Diseases)(...  -  Jun 1, 2006
NICE, FRANCE -- Tigecycline is as effective as levofloxacin in treating patients hospitalized with community-acquired pneumonia, results of a phase III ... Free with registration - Internal Medicine News - AccessMyLibrary.com

Tigecycline data reveals MRSA efficacy  -  Apr 5, 2005
Data from the first drug in a new class of antibiotics was presented at this year's ECCMID conference, which showed the drug demonstrated its efficacy ... DrugResearcher.com

Wyeth launches tigecycline in India  -  May 25, 2007
Wyeth Ltd has introduced Tygacil (tigecycline) in selected cities of India following its approval by the Drug Controller General of India. ... pharmabiz.com

Tigecycline in Vitro Activity Against Often Difficult to Treat...  -  Apr 4, 2006
By Chris Berrie. NICE, FRANCE -- April 4, 2006 -- The activity of the new glycylcycline antibiotic tigecycline (GAR-936) against a wide spectrum of ... DG News

New Data Highlight TYGACIL (tigecycline) In Vitro Activity Against …  -  Dec 16, 2005
WASHINGTON, Dec. 16 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , presented data today from multiple studies that indicate the in ... Free with registration - PR Newswire - AccessMyLibrary.com

Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 ...  -  Dec 8, 2008
...were as efficacious as the FDA approved dosing regime for tigecycline in the treatment of complicated skin and skin structure infections (cSSSI). ... RedOrbit

Tigecycline (Tygacil)  -  Sep 1, 2005
By Jessica C. Song, MA, PharmD, and Hyunah Eom, PharmD. Jessica Song is Assistant Professor of Pharmacy Practice, University of the Pacific, Stockton, CA. ... Pay-Per-View - Infectious Disease Alert - Factiva, from Dow Jones

… comparing the safety and efficacy of tigecycline with ampicillin...  -  Dec 1, 2007
Sponsored by Wyeth. The purpose of this study is to compare the safety and efficacy of the antibiotic tigecycline with other antibiotics, ... $4.95 - Journal of Drugs in Dermatology - ECNext

… comparing the safety and efficacy of tigecycline with ampicillin...  -  Jul 1, 2007
Sponsored by Wyeth. The purpose of this study is to compare the safety and efficacy of the antibiotic tigecycline with other antibiotics, ... $4.95 - Journal of Drugs in Dermatology - ECNext

… data suggests that the antibiotic Tygacil (tigecycline) is...  -  Dec 19, 2005
Tigecycline is not affected by these enzymes. ... Among the data presented are results from the Tigecycline Evaluation Surveillance Trial (TEST) ... OnMedica

Tigecycline tested as CAP therapy.(Infectious Diseases) | Article...  -  Dec 1, 2006
Tigecycline tested as CAP therapy.(Infectious Diseases) ... find Internal Medicine News articles. SAN FRANCISCO -- Tigecycline appeared to be comparable in ... Pay-Per-View - Internal Medicine News - HighBeam Research

Press Release: More Clinical Data Required to Support European …  -  Apr 23, 2008
Indications TYGACIL(R) (tigecycline) is indicated for the treatment of adults with: ... Article: New Data Examines TYGACIL (Tigecycline) in Patients with . ... Pay-Per-View - PR Newswire - HighBeam Research

Tigecycline promising for serious skin infections.(News)  -  Feb 1, 2005
WASHINGTON -- Tigecycline, a novel broad-spectrum antibiotic, appears effective in treating a variety of serious infections, including those caused by ... Pay-Per-View - Skin & Allergy News - Factiva, from Dow Jones

… Release: New Data Examines TYGACIL (Tigecycline) in Patients with ...  -  Sep 29, 2006
New Data Examines TYGACIL (Tigecycline) in Patients with Community-Acquired Pneumonia. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

FDA Approves Superbug Antibiotic, Tygacil (tigecycline)  -  Jun 20, 2005
The US FDA has approved Tygacil™ (tigecycline), a novel IV antibiotic with a broad spectrum of antimicrobial activity, including activity against the ... i-newswire.com

Antibiotic Resistance; Tigecycline is presented in a critical analysis  -  Sep 12, 2006
2006 SEP 12 - (NewsRx.com) -- Researchers present a critical analysis of tigecycline in a recent issue of Clinical Infectious Diseases. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

FDA Approvals: Tygacil, Keppra, Enbrel  -  Jun 30, 2005
On July 15, the FDA approved tigecycline (Tygacil injection, made by Wyeth ... In the studies, empiric monotherapy with tigecycline yielded cIAI cure rates ... Medscape

… Broad-spectrum Antibiotic Tygacil* (tigecycline) Receives Approval...  -  May 4, 2006
Tygacil* (tigecycline) is the first antibiotic in a new class called glycylcyclines approved in Europe. Tygacil is produced by Wyeth and is indicated for ... Medical News Today - Medical News Today (press release)

Press Release: Wyeth Receives Approvable Letter from FDA for TYGACIL …  -  May 29, 2008
Article: New Data Highlight TYGACIL (tigecycline) In Vitro Activity ... ... These data were among 39 tigecycline ... S. within the past few years. ... Pay-Per-View - PR Newswire - HighBeam Research

… Broad-Spectrum Antibiotic Tygacil (Tigecycline) Receives Approval...  -  May 2, 2006
MAIDENHEAD, UNITED KINGDOM -- May 2, 2006 – Tygacil® (tigecycline) is the first antibiotic in a new class called glycylcyclines approved in Europe. ... DG News

Press Release: New Data Highlight TYGACIL (tigecycline) In Vitro...  -  Dec 16, 2005
New Data Highlight TYGACIL (tigecycline) In Vitro Activity Against Resistant Gram-Negative and Extended-Spectrum Beta-Lactamase-Producing Bacteria. from PR ... Pay-Per-View - PR Newswire - HighBeam Research

New Data Examines TYGACIL (Tigecycline) in Patients with Community- …  -  Sep 29, 2006
MADISON, NJ, Sept. 29 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , presented data today from Phase III studies in patients with ... Free with registration - PR Newswire - AccessMyLibrary.com

… of arbekacin, daptomycin, and tigecycline on staphylococci revealed  -  Jan 17, 2005
2005 JAN 17 - (NewsRx.com & NewsRx.net) -- Recently published research from the United States reported on the testing of clinical glycopeptide-intermediate ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Press Release: FDA Accepts Wyeth's Supplemental New Drug …  -  Oct 24, 2007
Article: New Data Highlight TYGACIL (tigecycline) In Vitro Activity ... ... These data were among 39 tigecycline ... S. within the past few years. ... Pay-Per-View - PR Newswire - HighBeam Research

Tigecycline promising for serious skin infections.(News) | Article...  -  Feb 1, 2005
Tigecycline promising for serious skin infections.(News) ... find Skin & Allergy News articles. WASHINGTON -- Tigecycline, a novel broad-spectrum antibiotic ... Pay-Per-View - Skin & Allergy News - HighBeam Research

tigecycline Wyeth recommended for approval, EU (bacterial infection).  -  Mar 6, 2006
Tigecycline, a glycylcycline antibiotic, was launched in the USA in July 2005 for ... tigecycline, tigecycline, tigilcycline, GAR 936, WAY-GAR 936, TYGACIL, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Press Release: More Clinical Data Required to Support European …  -  Apr 23, 2008
Indications TYGACIL(R) (tigecycline) is indicated for the treatment of adults ... The product, tigecycline (Tygacil) joins the oxazolidinones (Pfizer's ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Tigecycline promising for complicated infections.(Rx) | Article from...  -  Jan 15, 2005
Tigecycline promising for complicated infections.(Rx) ... find Internal Medicine News articles. WASHINGTON -- Tigecycline, a novel broad-spectrum antibiotic ... Pay-Per-View - Internal Medicine News - HighBeam Research

Article: Tigecycline on horizon for community-acquired pneumonia.( …  -  Dec 1, 2006
Tigecycline on horizon for community-acquired pneumonia.(Infectious Diseases) ... find Family Practice News articles. San Francisco -- Tigecycline appeared ... Pay-Per-View - Family Practice News - HighBeam Research

Which Antibiotics Are Time- or Concentration-Dependent?  -  Oct 24, 2007
Could you provide a list of antibiotics that are time-dependent and concentration-dependent, including the new agent tigecycline? ... Medscape

… of arbekacin, daptomycin, and tigecycline on staphylococci revealed  -  Jan 21, 2005
2005 JAN 21 - (NewsRx.com & NewsRx.net) -- Recently published research from the United States reported on the testing of clinical glycopeptide-intermediate ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

와�?�어스, 항�?제 '타�?�가실' 약가 확정  -  Oct 14, 2008
...타�?�가실�?� 타�?�그사�?��?�린(tigecycline)�?��?�는 새로운 계열�?� 항�?제로, 피부 �? 연부 조�?�?염과 복강내 �?염�?� 치료제로 사용�?� 예정�?�다. ... 투�?뉴스

… of arbekacin, daptomycin, and tigecycline on staphylococci revealed  -  Jan 22, 2005
2005 JAN 22 - (NewsRx.com & NewsRx.net) -- Recently published research from the United States reported on the testing of clinical glycopeptide-intermediate ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

… Broad-Spectrum Antibiotic Tygacil[x] (tigecycline) Receives...  -  May 2, 2006
New Broad-Spectrum Antibiotic Tygacil[x] (tigecycline) Receives Approval for Use in Europe Today. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research

New data highlight Tygacil (tigecycline) in vitro activity against...  -  Dec 16, 2005
Among the data presented are results from the Tigecycline Evaluation Surveillance Trial (TEST) demonstrating tigecycline's in vitro activity against ... Pay-Per-View - Company Reports - Factiva, from Dow Jones

tigecycline Wyeth marketed, UK, Ireland (bacterial infection).  -  May 29, 2006
During May 2006, Wyeth launched intravenous tigecycline (TYGACIL), ... tigecycline, tigecycline, tigilcycline, GAR 936, WAY-GAR 936, TYGACIL, J1X, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

… Release: FDA Grants Tygacil(TM) (Tigecycline) NDA Priority Review ...  -  Jan 28, 2005
FDA Grants Tygacil(TM) (Tigecycline) NDA Priority Review Status; Wyeth Seeking Expedited Approval For Treatment of Complicated Intra-abdominal Infections ... Pay-Per-View - PR Newswire - HighBeam Research

… FDA approval for Tygacil (tigecycline).(Pipeline) - Medical...  -  Aug 1, 2005
...find Medical Marketing & Media articles. Wyeth received FDA approval for Tygacil (tigecycline), an IV antibiotic with a broad spectrum of antimicrob... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Tygacil[TM] (tigecycline).(New Drug)(Brief Article)  -  Aug 1, 2005
Tygacil[TM] (tigecycline).(New Drug)(Brief Article). Clinician Reviews August , 2005. Wyeth Pharmaceuticals Tygacil, a broad-spectrum intravenous antibiotic ... $4.95 - Clinician Reviews - ECNext

FDA Grants Antibiotic Tygacil(TM) NDA Priority Review Status  -  Jan 31, 2005
FDA ) granted priority review status to the company's New Drug Application ( NDA ) for the investigational IV antibiotic Tygacil( TM ) ( tigecycline ). ... i-newswire.com

Wyeth 'superbug' antibiotic launched in UK  -  Jul 24, 2006
Tygacil, or tigecycline, is a broad-spectrum IV treatment for "difficult to treat" infections caused by bacteria that have developed a resistance to some ... Hays Pharma

This injectable is first in new class of antibiotics.(Tygacil for...  -  Jul 11, 2005
Thus the approval of Wyeth Pharmaceuticals' Tygacil (tigecycline) for ... Tigecycline exhibits a broad spectrum of activity and is approved for the ... Free with registration - Drug Topics - AccessMyLibrary.com

Article: TYGACIL approved for treatment of patients with CAP.(RECENT ...  -  Jul 1, 2008
Article: New Data Examines TYGACIL (Tigecycline) in Patients with ... ... Administration (FDA) today approved Tygacil(TM) (tigecycline), ... Pay-Per-View - Pharmaceutical Processing - HighBeam Research

Superbug Warning: New Report Warns MRSA Is Reaching Epidemic …  -  Dec 15, 2006
Tigecycline is one of a limited number of new broad-spectrum antibiotics ... Tigecycline is a useful new alternative broad spectrum antibiotic option that ... Medical News Today - Medical News Today (press release)

New Antibiotic In Fight Against "superbugs"  -  Jul 22, 2006
The introduction of tigecycline in the UK comes at absolutely the right time and ... Tigecycline has been licensed for use in the UK as a treatment for a ... Medical News Today - Medical News Today (press release)

A comparison of available and investigational antibiotics for...  -  Jan 1, 2007
Tigecycline, a glycylcycline derived from minocycline, has been approved by the ... Tigecycline is derived from minocycline, which is a tetracycline and a ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com

惠�?计划推出新型抗生素  -  Feb 16, 2005
...近日，美国食�?和�?��?管�?�局（FDA）给予惠�?公�?�的研究性�?�脉用抗生素替加环素TygacilTM (tigecycline)的新�?�申请优先评估地�?。得到优先地�?的新�?��?味�?�该产�?，如果 ... 人民网

Much needed new antibiotic in fight against 'superbugs'  -  Jul 20, 2006
The introduction of tigecycline in the UK comes at absolutely the right time ... Tigecycline was licensed by the European Commission for use in Europe on ... eurekalert.org

Much Needed New Antibiotic in Fight Against 'Superbugs'  -  Jul 8, 2006
The introduction of tigecycline in the UK comes at absolutely the right time and ... Tigecycline has been licensed for use in the UK as a treatment for a ... Gate2Biotech

Much needed new antibiotic in fight against 'superbugs'  -  Apr 24, 2006
The introduction of tigecycline in the UK comes at absolutely the right time ... Tigecycline was licensed by the European Commission for use in Europe on ... PsychCentral.com

Antibiotics; New findings from the United States and France in the...  -  Oct 21, 2006
Study 1: Researchers present a critical analysis of tigecycline in a recent issue of ... According to their report, "Tigecycline (GAR-936) is the first ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

New antibiotic class battles resistant infections.  -  Feb 7, 2005
Tigecycline (Tygacil, Wyeth) is one of a slim list of new antibiotics in development ... Tigecycline, a derivative of minocycline, belongs to a new class of ... $9.94 - Drug Topics - Alacra Store

Antibiotics; New findings from the United States and France in the...  -  Oct 22, 2006
Study 1: Researchers present a critical analysis of tigecycline in a recent issue of ... According to their report, "Tigecycline (GAR-936) is the first ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones

Press Release: Oritavancin Demonstrates Potent and Rapid In Vitro …  -  Sep 19, 2007
Article: New Data Highlight TYGACIL (tigecycline) In Vitro ... PR Newswire; December 16, ... Article: In vitro activity of tigecycline and comparators ... ... Pay-Per-View - PR Newswire - HighBeam Research

… the safety and efficacy of a once-daily dose of tigecycline vs...  -  Dec 1, 2007
Condition Intervention Phase Bacterial Infections Drug: tigecycline Phase III Diabetic Foot Osteomyelitis Study ID Numbers: 3074K5-319 ... $4.95 - Journal of Drugs in Dermatology - ECNext

Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicat...  -  Jul 15, 2008
A secondary endpoint for the study is the assessment of clinical efficacy of RX-3341 compared to tigecycline in patients with cSSSIs caused by methicillin- ... Lifescience-online

Antimicrobial Resistance; Antimicrobial agents have excellent...  -  Oct 17, 2006
..."Ceftobiprole, daptomycin, and tigecycline showed high activity against all ... Denis continued, "The MIC distribution of daptomycin and tigecycline was not ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

International Approvals: Tygacil, DepoDur, and Zyvox  -  May 8, 2006
May 8, 2006 — The European Commission has approved tigecycline injection for ... In the studies, empiric monotherapy with tigecycline yielded a cIAI cure ... Medscape

Update on Antibiotic Resistance in Hospitals  -  Jun 16, 2006
Tigecycline has in vitro activity against MRSA, and a broad spectrum of ... Linezolid, daptomycin, and tigecycline are all active in vitro against the ... Medscape

Rib-X starts Ph II trial of RX-3341 in cSSSI.  -  Jul 21, 2008
A secondary endpoint for the study is the assessment of clinical efficacy of RX-3341 compared to tigecycline in patients with cSSSIs caused by ... $9.94 - Pharma Marketletter - Alacra Store

Press Release: Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX...  -  Jul 15, 2008
A secondary endpoint for the study is the assessment of clinical efficacy of RX-3341 compared to tigecycline in patients with cSSSIs caused by methicillin- ... Pay-Per-View - PR Newswire - HighBeam Research

Resistant 'superbugs' create need for novel antibiotics.(Reprint)  -  Feb 1, 2007
Tigecycline binds to bacterial ribosomes, inhibiting bacterial protein ... Tigecycline was FDA approved in 2005 for intravenous administration only ("FDA ... $4.95 - Dermatology Nursing - ECNext

Press Release: FDA APPROVES TYGACIL(TM), FIRST-IN-CLASS …  -  Jun 16, 2005
Article: FDA Grants Tygacil(TM) (Tigecycline) NDA Priority Review ... ... Article: New Data Examines TYGACIL (Tigecycline) in Patients with ... ... Pay-Per-View - PR Newswire Europe - HighBeam Research

ICAAC: Tygacil Beats Resistant Acinetobacter  -  Sep 29, 2006
Note that this study suggests that the antibiotic Tygacil (tigecycline) can stop such ... "Almost all tigecycline use is off-label," Dr. Rapp said. ... MedPage Today

Resistant 'superbugs' create need for novel antibiotics.(Nursing …  -  Feb 1, 2006
Tigecycline binds to bacterial ribosomes, inhibiting bacterial protein ... Tigecycline was FDA approved in 2005 for intravenous administration only ("FDA ... $4.95 - MedSurg Nursing - ECNext

Dissemination of multidrug-resistant bacteria into the Arctic.( …  -  Jan 1, 2008
...displayed isolated fosfomycin resistance with MIC values of 256 mg/L and 1024 mg/L. No resistance to gentamicin, imipenem, or tigecycline was observed. ... Free with registration - Emerging Infectious Diseases - AccessMyLibrary.com

Upside Endeavors has been engaged for global publication management …  -  Nov 1, 2005
Upside Endeavors has been engaged for global publication management and U.S. advocacy development for Wyeth's injectable antibiotic Tygacil (tigecycline). ... $9.94 - Medical Marketing & Media - Alacra Store

Upside Endeavors has been engaged for global publication management …  -  Nov 1, 2005
Upside Endeavors has been engaged for global publication management and US advocacy development for Wyeth's injectable antibiotic Tygacil (tigecycline). Pay-Per-View - Medical Marketing & Media - HighBeam Research

Selected biotechnology, biotech-related, small-molecule and other FDA...  -  Feb 27, 2006
...(lenalidomide) SymlinAmylin Pharmaceuticals Inc. (pramlintide acetate injection) Tygacil Wyeth (tigecycline injection) VIGIV, Vaccinia Immune Globulin ... Pay-Per-View - Chain Drug Review - HighBeam Research

Recente informatie  -  Oct 23, 2007
Tigecycline, intraveneus toegediend, wordt voorgesteld voor de behandeling in ... Rekening houdend met de geringere ervaring met tigecycline en met zijn ... Belgisch centrum voor farmacotherapeutis...

No ESKAPE! New Drugs Against MRSA, Other Superbugs Still Lacking  -  Dec 1, 2008
One drug, tigecycline, might work against these infections. There is nothing else in the pipeline. IDSA is an organization of physicians, scientists, ... webwire.com

Wyeth Receives Approvable Letter From FDA For TYGACIL For The …  -  May 30, 2008
The two studies (N=418, N=434) were conducted at 116 sites in 28 countries across the globe and evaluated the efficacy and safety of tigecycline compared ... Medical News Today - Medical News Today (press release)

Wyeth introduces Tygacil in India  -  Jun 30, 2007
Wyeth has introduced Tygacil (tigecycline) in select cities in India following its ... Each Tygacil vial contains 50 mg tigecycline lyophilized powder for ... Express Pharma

Meropenem for tough diabetic skin infections.(Dermatologic Therapy) |...  -  Mar 1, 2006
Article: Tigecycline promising for serious skin ... ... WASHINGTON -- Tigecycline, a novel broad-spectrum antibiotic, appears effective in treating a ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Antibiotic for skin infections.(Products) | Article from Skin &...  -  Oct 1, 2005
Article: Tigecycline promising for serious skin ... ... WASHINGTON -- Tigecycline, a novel broad-spectrum antibiotic, appears effective in treating a ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Article: Diabetic foot infections: learnings and ambitions.(Clinical...  -  Sep 22, 2007
Condition Intervention Phase Bacterial Infections Drug: tigecycline Phase III Diabetic Foot Osteomyelitis Study ID Numbers: 3074K5-319 ClinicalTrials ... ... Pay-Per-View - Diabetic Foot - HighBeam Research

Article: Antibiotic against superbugs is delayed.(Stock price)(Brief...  -  Apr 7, 2008
Condition Intervention Phase Bacterial Infections Drug: tigecycline Phase III Diabetic Foot Osteomyelitis Study ID Numbers: 3074K5-319 ClinicalTrials ... ... Pay-Per-View - Chemistry and Industry - HighBeam Research

Tygacil Receives 'Positive Opinion' From CHMP, Europe  -  Mar 3, 2006
TYGACIL is contraindicated in patients with known hypersensitivity to tigecycline. -- TYGACIL should be administered with caution in patients with known ... Medical News Today - Medical News Today (press release)

Article: Garenoxacin shows promise for community-acquired pneumonia.(...  -  Jan 1, 2007
Article: New Data Examines TYGACIL (Tigecycline) in Patients with ... ... Article: Tigecycline on horizon for community-acquired ... ... Pay-Per-View - Internal Medicine News - HighBeam Research

Need for new drugs to tackle superbugs'.  -  Jun 6, 2007
Tigecycline has generated much enthusiasm due to its ability to target both gram-positive and gram-negative organisms; its disadvantage being the lack of ... $4.95 - M2 Presswire - ECNext

No protection against germs.  -  Apr 11, 2006
Wyeth's antibiotic tigecycline, which was recently approved in the US, ... Tigecycline is also effective against tetracycline-resistant bacteria. ... Pay-Per-View - Handelsblatt Wirtschafts- und Finanzzeit... - Factiva, from Dow Jones

Press Release: Study Shows Once-Daily AVELOX(R) as Effective as Multi...  -  Jul 25, 2006
Article: Phase III Study Examines Activity of Tigecycline in Patients With ... ... This study compared tigecycline ... empiric combination treatment for ... Pay-Per-View - PR Newswire - HighBeam Research

Need for drugs to tackle "superbugs".  -  Jun 18, 2007
Tigecycline has generated much enthusiasm due to its ability to target both Gram-positive and Gram-negative organisms, however, its disadvantage is the lack ... $9.94 - Pharma Marketletter - Alacra Store

Press Release: Efficacy of Once-Daily AVELOX(R) in Treating …  -  Sep 29, 2006
Article: Phase III Study Examines Activity of Tigecycline in Patients With ... ... This study compared tigecycline ... empiric combination treatment for ... Pay-Per-View - PR Newswire - HighBeam Research

Daptomycin vs. resistant blood infections.(Infectious Diseases) |...  -  Jan 15, 2005
Resistance is developing. Daptomycin: Intravenous only, but effective for skin/soft tissue infections. Tigecycline: The newest antibiotic is intravenous ... ... Pay-Per-View - Internal Medicine News - HighBeam Research

MRSA increases for sixth year running in EU hospitals.(methicillin- …  -  Dec 18, 2006
US drug major Wyeth's Tygacil (tigecycline) is one of a small number of ... Tigecycline is a useful new alternative broad spectrum antibiotic option that ... $4.95 - Pharma Marketletter - ECNext

Article: Diabetic foot infection: dispelling the myths.(Guest...  -  Mar 22, 2005
Condition Intervention Phase Bacterial Infections Drug: tigecycline Phase III Diabetic Foot Osteomyelitis Study ID Numbers: 3074K5-319 ClinicalTrials ... ... Pay-Per-View - Diabetic Foot - HighBeam Research

Factiva Search  -  Aug 29, 2006
Antimicrobials; Tigecycline is newly approved glycylcycline antimicrobial agent ... 2006 AUG 29 - (NewsRx.com) -- Tigecycline is a new glycylcycline ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Factiva Search  -  Nov 15, 2005
Antibiotics; Standardization of tigecycline MIC testing method requires fresh medium or Oxyrase. 15 November, 2005 Life Science Weekly ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Factiva Search  -  Nov 8, 2005
2005 NOV 8 - (NewsRx.com) -- TREK Diagnostic Systems recently received 510(k) clearance on Tigecycline for Sensititre ... ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Factiva Search  -  Jan 15, 2005
Tigecycline promising for complicated infections.(Rx). 15 January, 2005 ... WASHINGTON -- Tigecycline, a novel broad-spectrum antibiotic, appears effective ... Pay-Per-View - Internal Medicine News - Factiva, from Dow Jones

Factiva Search  -  Jun 1, 2006
Tigecycline matches levofloxacin vs. pneumonia. ... NICE, FRANCE -- Tigecycline is as effective as levofloxacin in treating patients hospitalized with ... Pay-Per-View - Internal Medicine News - Factiva, from Dow Jones

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.